Black Diamond Therapeutics (BDTX) Insider Trading & Ownership

$4.76

-0.02 (-0.42%)

(As of 09/20/2024 ET)

Current Insider Ownership Percentage: 8.87%
Number Of Insiders Buying (Last 12 Months): 1
Amount Of Insider Buying (Last 12 Months): $936,000.00
Number Of Insiders Selling (Last 12 Months): 0

Get BDTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Black Diamond Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

BDTX Insider Buying and Selling by Quarter

Ad Behind the Markets

Ex-Wall Street CEO reveals “Millionaire-Maker” Superdrug

Science Magazine called it the "breakthrough of the year"... With projections of 8,966% growth in the next four years.

Click here for our #1 "Retirement Window" Stock >>>

Black Diamond Therapeutics Insider and Congressional Trades History

Transaction Type

Time Frame

Start Date

End Date

Export to Excel

Transaction Date	Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Details
10/17/2023	Growth N V Biotech	Major Shareholder	Buy	400,000	$2.34	$936,000.00

(Data available from 1/1/2013 forward)

BDTX Insider Trading Activity - Frequently Asked Questions

: The list of insiders at Black Diamond Therapeutics includes Ali Behbahani, David M Epstein, Fang Ni, and Growth N V Biotech. Learn more on insiders at BDTX.
: 8.87% of Black Diamond Therapeutics stock is owned by insiders. Learn more on BDTX's insider holdings.
: The following insiders have purchased BDTX shares in the last 24 months: Ali Behbahani ($5,000,000.00), and Growth N V Biotech ($16,082,240.84).
: Insiders have purchased a total of 4,497,217 BDTX shares in the last 24 months for a total of $21,082,240.84 bought.
: The following insider sold BDTX shares in the last 24 months: David M Epstein ($167,500.00).
: Insiders have sold a total of 25,000 Black Diamond Therapeutics shares in the last 24 months for a total of $167,500.00 sold.